Northern Trust’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.8M Buy
460,510
+42,251
+10% +$995K ﹤0.01% 2025
2025
Q1
$10M Sell
418,259
-36,748
-8% -$883K ﹤0.01% 2032
2024
Q4
$19.2M Buy
455,007
+89,707
+25% +$3.79M ﹤0.01% 1714
2024
Q3
$16.1M Sell
365,300
-219
-0.1% -$9.68K ﹤0.01% 1768
2024
Q2
$13.2M Sell
365,519
-6,935
-2% -$251K ﹤0.01% 1828
2024
Q1
$16.1M Buy
372,454
+50,619
+16% +$2.18M ﹤0.01% 1741
2023
Q4
$4.95M Buy
321,835
+26,331
+9% +$405K ﹤0.01% 2526
2023
Q3
$4.05M Buy
295,504
+18,041
+7% +$247K ﹤0.01% 2568
2023
Q2
$4.45M Buy
277,463
+84,078
+43% +$1.35M ﹤0.01% 2568
2023
Q1
$1.5M Buy
193,385
+67,904
+54% +$527K ﹤0.01% 3069
2022
Q4
$2.43M Buy
125,481
+10,611
+9% +$205K ﹤0.01% 2890
2022
Q3
$2.45M Buy
114,870
+2,400
+2% +$51.1K ﹤0.01% 2908
2022
Q2
$1.53M Buy
112,470
+3,063
+3% +$41.7K ﹤0.01% 3200
2022
Q1
$2.57M Buy
109,407
+31,554
+41% +$741K ﹤0.01% 2966
2021
Q4
$2.08M Buy
77,853
+18,538
+31% +$495K ﹤0.01% 3205
2021
Q3
$1.03M Buy
+59,315
New +$1.03M ﹤0.01% 3543